Tofidence® (Tocilizumab-bavi) sold under the brand name 施瑞立® in china, is a monoclonal antibody that binds to interlukin-6 receptors and is used to treat various inflammatory autoimmune conditions, including rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and systemic juvenile idiopathic arthritis.
Chinese Version
Brand name：Tofidence (施瑞立)
INN name：Tocilizumab (托珠单抗注射液)
Manufacturer：Bio-Thera (百奥泰生物)
Packaging：80mg/4ml/Box
Packaging：400mg/20ml/Box
Inquire&E-mail: care@100pei.com
Oct. 8, 2023，Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets, announced that its partner Biogen recently received notification from the United States Food and Drug Administration (FDA) on the approval of TOFIDENCE (tocilizumab-bavi) intravenous formulation, a biosimilar monoclonal antibody referencing ACTEMRA.
扫一扫 
